Gene therapy eases MS — modified virus reprograms immune system

A small clinical trial published in Nature suggests a modified virus can instruct the immune system to destroy disease-causing cells responsible for multiple sclerosis. The approach involves engineering immune therapy directly inside the patient's body, without removing cells first. Researchers describe it as a significant early proof of concept.